转胺酶2在癌症中的作用:最新情况
Elisabetta Zaltron1, Federica Vianello1, Alessia Ruzza1
1Department of Biology, University of Padua, 35131 Padua, Italy.
International journal of molecular sciences
|March 13, 2024
概括
转胺酶2型 (TG2) 是一种多功能酶,参与细胞存活和死亡. 它在癌症中的作用是复杂的,根据组织背景,它充当瘤基因和瘤抑制剂.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 转胺酶2型 (TG2) 是一种广泛表达的酶,调节细胞通路.
- TG2的多样化的细胞位置和功能影响细胞存活,死亡和平衡.
- TG2 影响瘤微环境,影响瘤的开始,生长和转移.
研究的目的:
- 探索TG2在细胞过程中的多方面的作用.
- 调查TG2对疾病发展和进展的贡献.
- 为了澄清TG2在癌症中的有争议的作用.
主要方法:
- 关于TG2功能和定位的文献综述.
- 对TG2在细胞内信号传递中的参与进行分析.
- 检查TG2对瘤微环境的影响.
主要成果:
- 除了蛋白质交叉链接之外,TG2表现出各种功能,包括酶和转位器活动.
- TG2在癌症中的作用取决于情境,有证据支持抗瘤和促瘤效应.
- TG2的功能是组织和细胞特异的,导致疾病的各种结果.
结论:
- TG2是细胞平衡和疾病进展的关键调节者.
- TG2在癌症中的双重作用需要进一步研究其组织特异性功能.
- 了解TG2的复杂生物学是开发向治疗的关键.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
14:57Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
14.4K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
